Literature DB >> 3421228

Corticosteroid-induced pancreatitis: a case report demonstrating recurrence with rechallenge.

R A Levine1, R F McGuire.   

Abstract

The existence of corticosteroid-induced pancreatitis remains controversial, despite the fact that more than 40 cases have been reported since its first description in 1955. No previous case reports have shown recurrence of pancreatitis after rechallenge with corticosteroids. This report describes a patient with stage IIIB Hodgkin's disease who received dexamethasone on three occasions for symptoms of spinal cord compression. On each occasion, the patient developed clinically evident pancreatitis shortly after beginning corticosteroid therapy. We believe that the close temporal relationship of the recurrences following rechallenge clearly implicates corticosteroids as an etiologic factor in this patient's pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421228

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

1.  Successful treatment of acute pancreatitis with hydrocortisone in a patient postadrenalectomy.

Authors:  Jiaan-Der Wang; San-Ging Shu; Ching-Shiang Chi; Chieh-Chung Lin
Journal:  Dig Dis Sci       Date:  2007-09-05       Impact factor: 3.199

Review 2.  The pancreas and inflammatory bowel diseases.

Authors:  K R Herrlinger; E F Stange
Journal:  Int J Pancreatol       Date:  2000-06

Review 3.  Ever-increasing diversity of drug-induced pancreatitis.

Authors:  Simcha Weissman; Muhammad Aziz; Ryan B Perumpail; Tej I Mehta; Rutwik Patel; James H Tabibian
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

4.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.